Literature DB >> 8014527

Toxic shock syndrome toxin 1 contributes to the arthritogenicity of Staphylococcus aureus.

A Abdelnour1, T Bremell, A Tarkowski.   

Abstract

Although enterotoxins have been implicated in disease states such as food poisoning and toxic shock syndrome, their role in infectious arthritis is not known. To study the arthritogenic properties of toxic shock syndrome toxin 1 (TSST-1), two pairs of S. aureus strains isogenic for TSST-1 production were injected intravenously into healthy Swiss mice. Mice injected with TSST-1-secreting staphylococcal strains developed more frequent and more severe arthritis than did mice inoculated with the isogenic TSST-1-deficient counterparts. Immunohistochemical analysis of arthritic joints revealed an equal number of infiltrating phagocytes in both groups; however, mice inoculated with TSST-1-producing staphylococci had significantly more (P < .01) interleukin-2 receptor-expressing cells in the inflamed synovium than did mice that received the isogenic counterpart. Thus, TSST-1 is a virulence determinant in S. aureus arthritis in mice. The precise mechanism by which this toxin contributes to the development and progression of arthritis needs further investigation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8014527     DOI: 10.1093/infdis/170.1.94

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

Review 1.  Immune response to staphylococcal superantigens.

Authors:  T Krakauer
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Interleukin-10 ameliorates the outcome of Staphylococcus aureus arthritis by promoting bacterial clearance.

Authors:  I Gjertsson; O H Hultgren; A Tarkowski
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

3.  Role of intercellular adhesion molecule 1 in pathogenesis of staphylococcal arthritis and in host defense against staphylococcal bacteremia.

Authors:  M Verdrengh; T A Springer; J C Gutierrez-Ramos; A Tarkowski
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

Review 4.  The potential use of toxin antibodies as a strategy for controlling acute Staphylococcus aureus infections.

Authors:  Gordon Y C Cheung; Michael Otto
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

Review 5.  Role of superantigens in experimental arthritis.

Authors:  A Abdelnour; Y X Zhao; T Bremell; R Holmdahl; A Tarkowski
Journal:  Springer Semin Immunopathol       Date:  1996

6.  Complement depletion aggravates Staphylococcus aureus septicaemia and septic arthritis.

Authors:  E Sakiniene; T Bremell; A Tarkowski
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

7.  The effect of site-specific monoclonal antibodies directed to toxic shock syndrome toxin-1 in experimental Staphylococcus aureus arthritis.

Authors:  M Verdrengh; W Kum; A Chow; A Tarkowski
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

8.  Role of the staphylococcal accessory gene regulator (sar) in septic arthritis.

Authors:  I M Nilsson; T Bremell; C Rydén; A L Cheung; A Tarkowski
Journal:  Infect Immun       Date:  1996-11       Impact factor: 3.441

Review 9.  Interaction of staphylococci with bone.

Authors:  John A Wright; Sean P Nair
Journal:  Int J Med Microbiol       Date:  2009-11-03       Impact factor: 3.473

10.  Preferential induction of septic arthritis and mortality by superantigen-producing staphylococci.

Authors:  T Bremell; A Tarkowski
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.